WO2009054350A1 - 耐糖能異常の評価方法 - Google Patents

耐糖能異常の評価方法 Download PDF

Info

Publication number
WO2009054350A1
WO2009054350A1 PCT/JP2008/068981 JP2008068981W WO2009054350A1 WO 2009054350 A1 WO2009054350 A1 WO 2009054350A1 JP 2008068981 W JP2008068981 W JP 2008068981W WO 2009054350 A1 WO2009054350 A1 WO 2009054350A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucose tolerance
impaired glucose
amino acid
evaluation
acid level
Prior art date
Application number
PCT/JP2008/068981
Other languages
English (en)
French (fr)
Inventor
Mitsuo Takahashi
Toshihiko Ando
Minoru Yamakado
Original Assignee
Ajinomoto Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co., Inc. filed Critical Ajinomoto Co., Inc.
Priority to JP2009538195A priority Critical patent/JPWO2009054350A1/ja
Priority to EP08843277A priority patent/EP2209001A4/en
Publication of WO2009054350A1 publication Critical patent/WO2009054350A1/ja
Priority to US12/662,559 priority patent/US20100261282A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Optics & Photonics (AREA)
  • Software Systems (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Evolutionary Computation (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)

Abstract

　血液中のアミノ酸の濃度を利用して耐糖能異常の状態を精度よく評価することができる耐糖能異常の評価方法、耐糖能異常評価装置、耐糖能異常評価方法、耐糖能異常評価システム、耐糖能異常評価プログラムおよび記録媒体などを提供することを課題とする。本発明にかかる耐糖能異常の評価方法は、評価対象から採取した血液から、アミノ酸の濃度値に関するアミノ酸濃度データを測定し、測定した評価対象のアミノ酸濃度データに基づいて、評価対象につき、耐糖能異常の状態を評価する。
PCT/JP2008/068981 2007-10-25 2008-10-20 耐糖能異常の評価方法 WO2009054350A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009538195A JPWO2009054350A1 (ja) 2007-10-25 2008-10-20 耐糖能異常の評価方法、耐糖能異常評価装置、耐糖能異常評価方法、耐糖能異常評価システム、耐糖能異常評価プログラムおよび記録媒体、ならびに耐糖能異常の予防・改善物質の探索方法
EP08843277A EP2209001A4 (en) 2007-10-25 2008-10-20 METHOD FOR ASSESSING STROKEN GLUCOSE TOLERANCE
US12/662,559 US20100261282A1 (en) 2007-10-25 2010-04-22 Method of evaluating IGT, IGT-evaluating apparatus, IGT-evaluating method, IGT--evaluating system, IGT-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for IGT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-277793 2007-10-25
JP2007277793 2007-10-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/662,559 Continuation US20100261282A1 (en) 2007-10-25 2010-04-22 Method of evaluating IGT, IGT-evaluating apparatus, IGT-evaluating method, IGT--evaluating system, IGT-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for IGT

Publications (1)

Publication Number Publication Date
WO2009054350A1 true WO2009054350A1 (ja) 2009-04-30

Family

ID=40579455

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/068981 WO2009054350A1 (ja) 2007-10-25 2008-10-20 耐糖能異常の評価方法

Country Status (4)

Country Link
US (1) US20100261282A1 (ja)
EP (1) EP2209001A4 (ja)
JP (1) JPWO2009054350A1 (ja)
WO (1) WO2009054350A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014168125A1 (ja) * 2013-04-09 2014-10-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
US9182407B2 (en) 2007-06-25 2015-11-10 Ajinomoto Co., Inc. Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation
WO2016056631A1 (ja) * 2014-10-08 2016-04-14 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
US9971866B2 (en) 2011-06-30 2018-05-15 Ajinomoto Co., Inc. Method of evaluating fatty liver related disease, fatty liver related disease-evaluating apparatus, fatty liver related disease-evaluating method, fatty liver related disease-evaluating program product, fatty liver related disease-evaluating system, information communication terminal apparatus, and method of searching for prophylactic/ameliorating substance for fatty liver related disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000298131A (ja) * 1999-04-14 2000-10-24 Ryuzo Kawamori 前糖尿病状態の検出方法
JP2001190299A (ja) * 1999-11-01 2001-07-17 Asahi Kasei Corp 糖尿病予備群の検査方法
WO2003069328A1 (fr) 2002-02-14 2003-08-21 Ajinomoto Co., Inc. Procede d'analyse aminofonctionnelle et reactif analytique
WO2003083133A1 (fr) * 2002-03-29 2003-10-09 Asahi Kasei Pharma Corporation Methode de detection d'une intolerance legere au glucose ou d'une hyposecretion d'insuline
WO2004052191A1 (ja) 2002-12-09 2004-06-24 Ajinomoto Co., Inc. 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体
WO2005116629A1 (ja) 2004-05-26 2005-12-08 Ajinomoto Co., Inc. アミノ官能性化合物の分析方法及び装置
WO2006098192A1 (ja) 2005-03-16 2006-09-21 Ajinomoto Co., Inc. 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
EP2330219A3 (en) * 2000-04-14 2011-11-23 Metabolon, Inc. Method for drug discovery, disease treatment and diagnosis using metabolomics
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6865415B2 (en) * 2000-04-18 2005-03-08 Yamato Scale Co., Ltd. Visceral fat determining device
WO2006129513A1 (ja) * 2005-05-30 2006-12-07 Ajinomoto Co., Inc. 肝疾患評価装置、肝疾患評価方法、肝疾患評価システム、肝疾患評価プログラムおよび記録媒体
BRPI0617332A2 (pt) * 2005-10-11 2011-07-26 Tethys Bioscience Inc marcadores asoociados ao diabetes e mÉtodos de uso dos mesmos
WO2007110358A2 (en) * 2006-03-24 2007-10-04 Metanomics Gmbh Means and method for predicting diabetes
WO2008015929A1 (fr) * 2006-08-04 2008-02-07 Ajinomoto Co., Inc. procédé d'évaluation de syndrome métabolique, appareil D'ÉVALUATION DE SYNDROME MÉTABOLIQUE, système D'ÉVALUATION DE SYNDROME MÉTABOLIQUE, programme d'évaluation de syndrome métabolique et support d'enregistrement, et proc&
JPWO2009001862A1 (ja) * 2007-06-25 2010-08-26 味の素株式会社 内臓脂肪蓄積の評価方法
BRPI0815095B1 (pt) * 2007-07-17 2021-04-13 Metabolon, Inc Método de classificação de um indivíduo de acordo com a tolerância à glicose predita em tolerância à glicose normal (ngt), tolerância à glicose de jejum prejudicada (ifg), ou tolerância à glicose prejudicada (igt), para diabetes tipo 2, método de determinação da suscetibilidade de um indivíduo a diabetes tipo 2 e método de monitoramento da progressão ou regressão do pré- diabetes em um indivíduo
CN102326084A (zh) * 2009-02-19 2012-01-18 味之素株式会社 肥胖的评价方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000298131A (ja) * 1999-04-14 2000-10-24 Ryuzo Kawamori 前糖尿病状態の検出方法
JP2001190299A (ja) * 1999-11-01 2001-07-17 Asahi Kasei Corp 糖尿病予備群の検査方法
WO2003069328A1 (fr) 2002-02-14 2003-08-21 Ajinomoto Co., Inc. Procede d'analyse aminofonctionnelle et reactif analytique
WO2003083133A1 (fr) * 2002-03-29 2003-10-09 Asahi Kasei Pharma Corporation Methode de detection d'une intolerance legere au glucose ou d'une hyposecretion d'insuline
WO2004052191A1 (ja) 2002-12-09 2004-06-24 Ajinomoto Co., Inc. 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体
WO2005116629A1 (ja) 2004-05-26 2005-12-08 Ajinomoto Co., Inc. アミノ官能性化合物の分析方法及び装置
WO2006098192A1 (ja) 2005-03-16 2006-09-21 Ajinomoto Co., Inc. 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"Diagnosis and Classification of Diabates Mellitus", DIABATES CARE, vol. 20, 1997, pages 1183
"The Expert Committee on the Diagnosis and Classification of Diabates Mellitus", DIABATES CARE, vol. 26, 2003, pages 3160
FELIG, P.; MARLISS, E. ET AL., DIABATES, vol. 19, 1970, pages 727
FELIG, P.; MARLISS, E. ET AL., NEW ENGL. J. MED., vol. 281, 1969, pages 811
KO, G. ET AL., DIABATES CARE, vol. 21, 1998, pages 1221
KUZUYA, TAKESHI ET AL.: "Commission report on classification and diagnostic criteria for diabetes mellitus", JOURNAL OF THE JAPAN DIABETES SOCIETY, vol. 42, 1999, pages 3835
See also references of EP2209001A4
TOMINAGA, M. ET AL.: "The Funagata Diabates Study", DIABATES CARE, vol. 22, 1999, pages 920
WASIM, H. ET AL., CARDIOVASC DIABETOL., vol. 25, 2006, pages 10

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9182407B2 (en) 2007-06-25 2015-11-10 Ajinomoto Co., Inc. Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation
US9971866B2 (en) 2011-06-30 2018-05-15 Ajinomoto Co., Inc. Method of evaluating fatty liver related disease, fatty liver related disease-evaluating apparatus, fatty liver related disease-evaluating method, fatty liver related disease-evaluating program product, fatty liver related disease-evaluating system, information communication terminal apparatus, and method of searching for prophylactic/ameliorating substance for fatty liver related disease
KR102204498B1 (ko) 2013-04-09 2021-01-19 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램 제품, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
WO2014168125A1 (ja) * 2013-04-09 2014-10-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
JPWO2014168125A1 (ja) * 2013-04-09 2017-02-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
KR102362357B1 (ko) 2013-04-09 2022-02-15 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
KR20210007053A (ko) 2013-04-09 2021-01-19 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
KR20150140363A (ko) 2013-04-09 2015-12-15 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램 제품, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
JPWO2016056631A1 (ja) * 2014-10-08 2017-07-27 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
WO2016056631A1 (ja) * 2014-10-08 2016-04-14 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
JP2021081439A (ja) * 2014-10-08 2021-05-27 味の素株式会社 取得方法、評価装置、評価プログラムおよび評価システム
KR20170066409A (ko) 2014-10-08 2017-06-14 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
JP7215507B2 (ja) 2014-10-08 2023-01-31 味の素株式会社 取得方法、評価装置、評価プログラムおよび評価システム
KR102500075B1 (ko) * 2014-10-08 2023-02-16 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
KR20230028566A (ko) 2014-10-08 2023-02-28 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
KR102614827B1 (ko) * 2014-10-08 2023-12-19 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치

Also Published As

Publication number Publication date
US20100261282A1 (en) 2010-10-14
JPWO2009054350A1 (ja) 2011-03-03
EP2209001A1 (en) 2010-07-21
EP2209001A4 (en) 2010-10-27

Similar Documents

Publication Publication Date Title
WO2009001862A1 (ja) 内臓脂肪蓄積の評価方法
WO2012091843A3 (en) Systems and methods for evaluating range sensor calibration data
WO2014066913A3 (en) Health diagnostic systems and methods
WO2007038754A3 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
WO2009054351A1 (ja) 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラムおよび記録媒体
EP1953521A3 (en) System and method for detecting onset of structural failure
WO2010053410A8 (en) Method and system for combining sensor data
WO2007136980A3 (en) Diagnostic test media and methods for the manufacture thereof
WO2012122236A3 (en) Method and system to detect and diagnose alzheimer's disease
WO2009072204A1 (ja) 電子化計量装置の寿命推定方法および装置
DE602007009395D1 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
WO2008060694A3 (en) System and/or method for determining sufficiency of pseudorange measurements
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2009017013A1 (ja) き裂進展予測方法及びプログラム
WO2010014458A3 (en) Apparatus for lead length determination
WO2011042448A3 (en) Managing flow testing and the results thereof for hydrocarbon wells
WO2011021198A3 (en) Gas chromatographic analysis method and system
WO2012042211A3 (en) Glucose electrochemical measurement method with error detection
WO2010140779A3 (ko) 시료 채취/주입 기구 및 이를 포함하는 생체 데이터 측정용 세트
WO2014144223A3 (en) A noninvasive method for measuring metabolites for skin health
WO2007086998A3 (en) Method and system for evaluating groups of threaded connections
WO2008144114A8 (en) System and technique to remove perturbation noise from seismic sensor data
WO2010053800A3 (en) Method and apparatus for visual field monitoring
WO2007141023A3 (en) Method of determining enzymatic activity in biological media

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08843277

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009538195

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008843277

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE